Osaic Holdings’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.71K Buy
+139
New +$4.58K ﹤0.01% 6966
2026
Q1
Sell
-10
Closed -$351 7980
2025
Q4
$351 Buy
+10
New +$364 ﹤0.01% 7497
2025
Q1
Sell
-142
Closed -$3.65K 7629
2024
Q4
$3.65K Sell
142
-45
-24% -$956 ﹤0.01% 6355
2024
Q3
$3.1K Buy
187
+142
+316% +$2.46K ﹤0.01% 6420
2024
Q2
$864 Buy
+45
New +$903 ﹤0.01% 6858

Other funds holding NAMS

Osaic Holdings's NAMS Position: Q2 2026 in Review

Osaic Holdings opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 139 shares worth $4.71K. The stake represents ﹤0.01% of the portfolio and ranks #6966 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in NAMS as recently as Q4 2025.

Osaic Holdings first reported a position in NAMS in Q2 2024 and has held it in 5 quarters since. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Osaic Holdings held 139 shares of NewAmsterdam Pharma worth $4.71K as of Q2 2026.
  • NewAmsterdam Pharma was a new Osaic Holdings position in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6966 holding.
  • Osaic Holdings first reported a position in NewAmsterdam Pharma in Q2 2024 and has held it in 5 quarters since.
  • 195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.